• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Data supports limiting blood transfusions for moderate anemia

byCaitlyn HuiandDeepti Shroff Karhade
December 18, 2018
in Cardiology, Chronic Disease, Emergency, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The authors observed in this retrospective cohort study that transfusion rates decreased among patients from 2010 and 2014.

2. Paralleling decreasing transfusion rates, the authors observed a reduction in 6-month mortality rates among patients with moderate anemia from 2010 and 2014.

Evidence Rating Level: 2 (Good)

Study Rundown: Anemia is a common condition in hospitalized patients and is managed with blood transfusions when patients’ hemoglobin drops below a safe threshold. Randomized controlled trials have supported decreased red blood cell (RBC) transfusions and short-term tolerance of in-hospital anemia. The authors of this study aimed to describe the prevalence of anemia at and after hospital discharge, as well as associated morbidity and mortality events. The purpose was to assess long-term outcomes related to transfusion practice. Overall, the authors concluded that data supports limiting blood transfusions for moderate anemia among patients. Despite reductions in median hemoglobin level at discharge, pre-transfusion hemoglobin levels, and total blood transfusions, there were reductions in 6-month rehospitalization and mortality rates in patients with anemia. The main limitation of this study was that there were possible unmeasured confounding factors that the authors could not control for in the analysis. Further, the patients included represented patients from northern California and may not be representative of all the United States.

Click to read the study, published today in Annals of Internal Medicine

Click to read an accompanying editorial in Annals of Internal Medicine

Relevant Reading: Anemia and its clinical consequences on patients with chronic diseases

RELATED REPORTS

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

#VisualAbstract: Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis

Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis – the ASCEND-ID trial

In-Depth [retrospective cohort]: In this retrospective cohort study, the authors assessed a total of 445,371 surviving adults between January 2010 and December 2014, who had a total of 801 261 hospitalizations collectively. The main measurements were hemoglobin levels, RBC transfusions, re-hospitalizations and mortality events within 6 months of discharge from the hospital. It was found that there was an increase from 20-25% between 2010 and 2014 of moderate anemia at hospital discharge (defined as hemoglobin levels between 7 and 10 g/dL) (P < 0.001). The rates of RBC transfusions declined by 28% (39.8 to 28.5 RBC units per 1000 patients, P < 0.001). The 6-month adjusted mortality rate decreased from 16.1% to 15.6% (P = 0.004) during the study period.

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anemiablood transfusiontransfusion
Previous Post

Daily medication more cost-effective than monthly injections for opioid use disorder

Next Post

Risk of malformations in offspring likely minimal with use of ondansetron (Zofran) in first trimester

RelatedReports

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia
StudyGraphics

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

May 4, 2022
#VisualAbstract: Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis
StudyGraphics

#VisualAbstract: Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis

April 14, 2022
Being overweight and obese associated with increased incidence of chronic kidney disease
Chronic Disease

Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis – the ASCEND-ID trial

April 8, 2022
#VisualAbstract: Moderate-dose hydroxyurea does not decrease stroke incidence but may lower hospitalization rates in children with sickle cell anaemia, compared to low-dose hydroxyurea
StudyGraphics

#VisualAbstract: Moderate-dose hydroxyurea does not decrease stroke incidence but may lower hospitalization rates in children with sickle cell anaemia, compared to low-dose hydroxyurea

January 13, 2022
Next Post
Paternal factors associated with short interpregnancy interval

Risk of malformations in offspring likely minimal with use of ondansetron (Zofran) in first trimester

Fatty liver disease may independently predict high-risk coronary disease

2 Minute Medicine Rewind December 18, 2018

Ultrasound enhances gastrointestinal absorption of drugs at low frequencies

Opioids unlikely to provide clinically meaningful reduction in chronic non-cancer pain

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.